3347 — Hangzhou Tigermed Consulting Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$36.77bn
- HK$40.56bn
- CNY6.83bn
Annual cashflow statement for Hangzhou Tigermed Consulting Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1,734 | -2,421 | -2,961 | -3,204 | -3,376 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,424 | 1,358 | 1,150 | 1,097 | 1,118 |
| Capital Expenditures | -369 | -449 | -314 | -357 | -214 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2,414 | -2,341 | -1,220 | -4,383 | 706 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,783 | -2,789 | -1,534 | -4,739 | 492 |
| Financing Cash Flow Items | -643 | -621 | -488 | -638 | -571 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -163 | 809 | -7.81 | -1,702 | -1,927 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,582 | -596 | -383 | -5,351 | -326 |